FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:CACNA2D1-HGF (FusionGDB2 ID:12403)

Fusion Gene Summary for CACNA2D1-HGF

check button Fusion gene summary
Fusion gene informationFusion gene name: CACNA2D1-HGF
Fusion gene ID: 12403
HgeneTgene
Gene symbol

CACNA2D1

HGF

Gene ID

781

6654

Gene namecalcium voltage-gated channel auxiliary subunit alpha2delta 1SOS Ras/Rac guanine nucleotide exchange factor 1
SynonymsCACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3GF1|GGF1|GINGF|HGF|NS4|SOS-1
Cytomap

7q21.11

2p22.1

Type of geneprotein-codingprotein-coding
Descriptionvoltage-dependent calcium channel subunit alpha-2/delta-1calcium channel, L type, alpha 2 polypeptidecalcium channel, voltage-dependent, alpha 2/delta subunit 1dihydropyridine-sensitive L-type, calcium channel alpha-2/delta subunitvoltage-gated calciuson of sevenless homolog 1gingival fibromatosis, hereditary, 1guanine nucleotide exchange factor
Modification date2020031320200327
UniProtAcc

P54289

P14210

Ensembl transtripts involved in fusion geneENST00000356860, ENST00000356253, 
ENST00000423588, ENST00000464354, 
ENST00000535308, 		ENST00000222390, 
ENST00000457544, ENST00000444829, 
ENST00000453411, ENST00000423064, 
ENST00000354224, ENST00000453018, 
Fusion gene scores* DoF score6 X 8 X 4=1924 X 3 X 4=48
# samples 94
** MAII scorelog2(9/192*10)=-1.09310940439148
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(4/48*10)=-0.263034405833794
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: CACNA2D1 [Title/Abstract] AND HGF [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointCACNA2D1(81634739)-HGF(81388120), # samples:1
Anticipated loss of major functional domain due to fusion event.CACNA2D1-HGF seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneCACNA2D1

GO:0006816

calcium ion transport

1309651|11160515

HgeneCACNA2D1

GO:0051924

regulation of calcium ion transport

1309651


check buttonFusion gene breakpoints across CACNA2D1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across HGF (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4MESOTCGA-3U-A98I-01ACACNA2D1chr7

81634739

-HGFchr7

81388120

-


Top

Fusion Gene ORF analysis for CACNA2D1-HGF

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shiftENST00000356860ENST00000222390CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356860ENST00000457544CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356860ENST00000444829CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356860ENST00000453411CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356860ENST00000423064CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356860ENST00000354224CACNA2D1chr7

81634739

-HGFchr7

81388120

-
5CDS-5UTRENST00000356860ENST00000453018CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356253ENST00000222390CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356253ENST00000457544CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356253ENST00000444829CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356253ENST00000453411CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356253ENST00000423064CACNA2D1chr7

81634739

-HGFchr7

81388120

-
Frame-shiftENST00000356253ENST00000354224CACNA2D1chr7

81634739

-HGFchr7

81388120

-
5CDS-5UTRENST00000356253ENST00000453018CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000423588ENST00000222390CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000423588ENST00000457544CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000423588ENST00000444829CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000423588ENST00000453411CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000423588ENST00000423064CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000423588ENST00000354224CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-5UTRENST00000423588ENST00000453018CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000464354ENST00000222390CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000464354ENST00000457544CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000464354ENST00000444829CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000464354ENST00000453411CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000464354ENST00000423064CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000464354ENST00000354224CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-5UTRENST00000464354ENST00000453018CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000535308ENST00000222390CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000535308ENST00000457544CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000535308ENST00000444829CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000535308ENST00000453411CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000535308ENST00000423064CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-3CDSENST00000535308ENST00000354224CACNA2D1chr7

81634739

-HGFchr7

81388120

-
intron-5UTRENST00000535308ENST00000453018CACNA2D1chr7

81634739

-HGFchr7

81388120

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for CACNA2D1-HGF


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for CACNA2D1-HGF


check button Go to

FGviewer for the breakpoints of :-:

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
CACNA2D1

P54289

HGF

P14210

FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. Plays an important role in excitation-contraction coupling (By similarity). {ECO:0000250}.FUNCTION: Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types. Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization. {ECO:0000269|PubMed:15167892, ECO:0000269|PubMed:20624990}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for CACNA2D1-HGF


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for CACNA2D1-HGF


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for CACNA2D1-HGF


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneCACNA2D1P54289DB00308IbutilideActivatorSmall moleculeApproved
HgeneCACNA2D1P54289DB00308IbutilideActivatorSmall moleculeApproved
HgeneCACNA2D1P54289DB00308IbutilideActivatorSmall moleculeApproved
HgeneCACNA2D1P54289DB00308IbutilideActivatorSmall moleculeApproved
HgeneCACNA2D1P54289DB00401NisoldipineInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB00401NisoldipineInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB00401NisoldipineInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB00401NisoldipineInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB04838CyclandelateInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB04838CyclandelateInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB04838CyclandelateInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB04838CyclandelateInhibitorSmall moleculeApproved
HgeneCACNA2D1P54289DB00230PregabalinSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00230PregabalinSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00230PregabalinSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00230PregabalinSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00270IsradipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00270IsradipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00270IsradipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00270IsradipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00622NicardipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00622NicardipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00622NicardipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00622NicardipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00996GabapentinInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00996GabapentinInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00996GabapentinInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB00996GabapentinInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01023FelodipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01023FelodipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01023FelodipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01023FelodipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01054NitrendipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01054NitrendipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01054NitrendipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB01054NitrendipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB06712NilvadipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB06712NilvadipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB06712NilvadipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB06712NilvadipineInhibitorSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB08872Gabapentin enacarbilSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB08872Gabapentin enacarbilSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB08872Gabapentin enacarbilSmall moleculeApproved|Investigational
HgeneCACNA2D1P54289DB08872Gabapentin enacarbilSmall moleculeApproved|Investigational
TgeneHGFP14210DB01109HeparinSmall moleculeApproved|Investigational
TgeneHGFP14210DB01109HeparinSmall moleculeApproved|Investigational

Top

Related Diseases for CACNA2D1-HGF


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneCACNA2D1C1142166Brugada Syndrome (disorder)6CLINGEN;GENOMICS_ENGLAND;ORPHANET
HgeneCACNA2D1C0027796Neuralgia4CTD_human
HgeneCACNA2D1C0038870Neuralgia, Supraorbital4CTD_human
HgeneCACNA2D1C0042656Neuralgia, Vidian4CTD_human
HgeneCACNA2D1C0234247Neuralgia, Atypical4CTD_human
HgeneCACNA2D1C0234249Neuralgia, Stump4CTD_human
HgeneCACNA2D1C0264893Nodal rhythm disorder4CLINGEN
HgeneCACNA2D1C0348626Other specified cardiac arrhythmias4CLINGEN
HgeneCACNA2D1C0423711Neuralgia, Perineal4CTD_human
HgeneCACNA2D1C0423712Neuralgia, Iliohypogastric Nerve4CTD_human
HgeneCACNA2D1C0428908Sinus Node Dysfunction (disorder)4CLINGEN
HgeneCACNA2D1C0751371Neuralgia, Ilioinguinal4CTD_human
HgeneCACNA2D1C0751372Nerve Pain4CTD_human
HgeneCACNA2D1C0751373Paroxysmal Nerve Pain4CTD_human
HgeneCACNA2D1C1399226Ectopic rhythm4CLINGEN
HgeneCACNA2D1C2748542CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)4CLINGEN
HgeneCACNA2D1C4551804Brugada Syndrome 14CLINGEN
HgeneCACNA2D1C0020429Hyperalgesia3CTD_human
HgeneCACNA2D1C0458247Allodynia3CTD_human
HgeneCACNA2D1C0751211Hyperalgesia, Primary3CTD_human
HgeneCACNA2D1C0751212Hyperalgesia, Secondary3CTD_human
HgeneCACNA2D1C0751213Tactile Allodynia3CTD_human
HgeneCACNA2D1C0751214Hyperalgesia, Thermal3CTD_human
HgeneCACNA2D1C2936719Mechanical Allodynia3CTD_human
HgeneCACNA2D1C0003811Cardiac Arrhythmia1GENOMICS_ENGLAND
HgeneCACNA2D1C0007102Malignant tumor of colon1CTD_human
HgeneCACNA2D1C0009375Colonic Neoplasms1CTD_human
HgeneCACNA2D1C0011071Sudden death1GENOMICS_ENGLAND
HgeneCACNA2D1C0020538Hypertensive disease1CTD_human
HgeneCACNA2D1C0030193Pain1CTD_human
HgeneCACNA2D1C0151879Shortened QT interval1GENOMICS_ENGLAND
HgeneCACNA2D1C0234230Pain, Burning1CTD_human
HgeneCACNA2D1C0234238Ache1CTD_human
HgeneCACNA2D1C0234254Radiating pain1CTD_human
HgeneCACNA2D1C0458257Pain, Splitting1CTD_human
HgeneCACNA2D1C0458259Pain, Crushing1CTD_human
HgeneCACNA2D1C0751407Pain, Migratory1CTD_human
HgeneCACNA2D1C0751408Suffering, Physical1CTD_human
HgeneCACNA2D1C1865020Short QT Syndrome 11ORPHANET
TgeneHGFC0023893Liver Cirrhosis, Experimental7CTD_human
TgeneHGFC0027626Neoplasm Invasiveness2CTD_human
TgeneHGFC0033141Cardiomyopathies, Primary2CTD_human
TgeneHGFC0036529Myocardial Diseases, Secondary2CTD_human
TgeneHGFC0878544Cardiomyopathies2CTD_human
TgeneHGFC2239176Liver carcinoma2CTD_human
TgeneHGFC3711374Nonsyndromic Deafness2CLINGEN
TgeneHGFC0004114Astrocytoma1CTD_human
TgeneHGFC0004763Barrett Esophagus1CTD_human
TgeneHGFC0007137Squamous cell carcinoma1CTD_human
TgeneHGFC0011882Diabetic Neuropathies1CTD_human
TgeneHGFC0019189Hepatitis, Chronic1CTD_human
TgeneHGFC0019207Hepatoma, Morris1CTD_human
TgeneHGFC0019208Hepatoma, Novikoff1CTD_human
TgeneHGFC0023467Leukemia, Myelocytic, Acute1CTD_human
TgeneHGFC0023890Liver Cirrhosis1CTD_human
TgeneHGFC0023903Liver neoplasms1CTD_human
TgeneHGFC0023904Liver Neoplasms, Experimental1CTD_human
TgeneHGFC0026998Acute Myeloid Leukemia, M11CTD_human
TgeneHGFC0027627Neoplasm Metastasis1CTD_human
TgeneHGFC0027659Neoplasms, Experimental1CTD_human
TgeneHGFC0027819Neuroblastoma1CTD_human
TgeneHGFC0030193Pain1CTD_human
TgeneHGFC0030305Pancreatitis1CTD_human
TgeneHGFC0030567Parkinson Disease1CTD_human
TgeneHGFC0034069Pulmonary Fibrosis1CTD_human
TgeneHGFC0035126Reperfusion Injury1CTD_human
TgeneHGFC0040053Thrombosis1CTD_human
TgeneHGFC0042373Vascular Diseases1CTD_human
TgeneHGFC0086404Experimental Hepatoma1CTD_human
TgeneHGFC0087086Thrombus1CTD_human
TgeneHGFC0149519Chronic Persistent Hepatitis1CTD_human
TgeneHGFC0151744Myocardial Ischemia1CTD_human
TgeneHGFC0162557Liver Failure, Acute1CTD_human
TgeneHGFC0205768Subependymal Giant Cell Astrocytoma1CTD_human
TgeneHGFC0234230Pain, Burning1CTD_human
TgeneHGFC0234238Ache1CTD_human
TgeneHGFC0234254Radiating pain1CTD_human
TgeneHGFC0239946Fibrosis, Liver1CTD_human
TgeneHGFC0271673Symmetric Diabetic Proximal Motor Neuropathy1CTD_human
TgeneHGFC0271674Asymmetric Diabetic Proximal Motor Neuropathy1CTD_human
TgeneHGFC0271678Diabetic Mononeuropathy1CTD_human
TgeneHGFC0271680Diabetic Polyneuropathies1CTD_human
TgeneHGFC0271685Diabetic Amyotrophy1CTD_human
TgeneHGFC0271686Diabetic Autonomic Neuropathy1CTD_human
TgeneHGFC0280783Juvenile Pilocytic Astrocytoma1CTD_human
TgeneHGFC0280785Diffuse Astrocytoma1CTD_human
TgeneHGFC0334579Anaplastic astrocytoma1CTD_human
TgeneHGFC0334580Protoplasmic astrocytoma1CTD_human
TgeneHGFC0334581Gemistocytic astrocytoma1CTD_human
TgeneHGFC0334582Fibrillary Astrocytoma1CTD_human
TgeneHGFC0334583Pilocytic Astrocytoma1CTD_human
TgeneHGFC0338070Childhood Cerebral Astrocytoma1CTD_human
TgeneHGFC0345904Malignant neoplasm of liver1CTD_human
TgeneHGFC0345967Malignant mesothelioma1CTD_human
TgeneHGFC0393835Diabetic Asymmetric Polyneuropathy1CTD_human
TgeneHGFC0458257Pain, Splitting1CTD_human
TgeneHGFC0458259Pain, Crushing1CTD_human
TgeneHGFC0520463Chronic active hepatitis1CTD_human
TgeneHGFC0524611Cryptogenic Chronic Hepatitis1CTD_human
TgeneHGFC0547065Mixed oligoastrocytoma1CTD_human
TgeneHGFC0750935Cerebral Astrocytoma1CTD_human
TgeneHGFC0750936Intracranial Astrocytoma1CTD_human
TgeneHGFC0751074Diabetic Neuralgia1CTD_human
TgeneHGFC0751407Pain, Migratory1CTD_human
TgeneHGFC0751408Suffering, Physical1CTD_human
TgeneHGFC0949804Polyomavirus Infections1CTD_human
TgeneHGFC1258085Barrett Epithelium1CTD_human
TgeneHGFC1704230Grade I Astrocytoma1CTD_human
TgeneHGFC1842342DEAFNESS, AUTOSOMAL RECESSIVE 39 (disorder)1CTD_human;GENOMICS_ENGLAND
TgeneHGFC1876165Copper-Overload Cirrhosis1CTD_human
TgeneHGFC1879321Acute Myeloid Leukemia (AML-M2)1CTD_human
TgeneHGFC4721507Alveolitis, Fibrosing1CTD_human